Form 4 for EBS Emergent BioSolutions Inc.
Accepted 2022-11-15 00:00:00 ET · period of report 2022-11-11 · accession 0001367644-22-000146 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-11-15 | 2022-11-11 | EBS | Fox Jennifer Lynne | EVP, GC, Ext Aff, Corp Sec | F - Tax | $15.00 | -416 | 32.2K | -1% | -$6,240 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-11 | F | D | 416 | $15.00 | 32,211 | D | — | — | (F1) Represents shares of common stock of Emergent BioSolutions Inc withheld to pay tax liability on shares of restricted stock awarded pursuant to Rule 16b-3(d), which vested on November 11, 2022. |